Calyx Bio-Ventures Inc. (TSX VENTURE:CYX) (“Calyx” or the “Company”) is pleased to announce that its wholly owned subsidiary Cannigistics Agri-Solutions Corp. (“Cannigistics”) has launched its first consumer facing Cloud (LEAFHub) which is based on the company’s innovative “FocusPoint” Software Platform.
LEAFHub will be Canada’s first real-time, mass communication consumer cloud that provides the Canadian Medical Marijuana user a safe and secure forum to discuss, compare, evaluate, or otherwise locate and comment on the various products available in the market today. “We are confident that over time, the LEAFHub Cloud will become a very popular destination with both consumers and licensed producers,” states President and CEO, Roger Forde.
The next LEAFHub Cloud to launch will be Washington State, followed by Colorado, and ultimately (depending on the November 8th, 2016 referendum) California.
As each state may potentially have thousands of potential consumers, it necessary they each have their own unique implementation of the LEAFHub Cloud to ensure that any and all specific state laws are recognized and adhered to.
LEAFHub Cloud could easily become a standard method of consumer mass communication and information exchange for both the recreational and medical marijuana industry in these states.
The rollouts of these Clouds are scheduled to begin the 2nd week of November 2016 with an anticipated completion date by the 3rd week of December 2016.
Calyx’s wholly owned subsidiary, Cannigistics Agri-Solutions Corp, is a software development company that has created a software platform that is well-suited to advanced indoor agriculture. The Cannigistics software platform is designed to enhance the efficiency and effectiveness of indoor agricultural operations, and positions Cannigistics to be an industry leader in agri-software solutions by providing businesses with advanced controls over various aspects of their operations. Additionally, Calyx owns a portfolio of proprietary intellectual property with applications in crop enhancement.
For further information, please visit www.calyxbio.com.
ON BEHALF OF THE BOARD OF DIRECTORS,
Roger Forde, Director, President and Chief Executive Officer
Forward-Looking Statements: This document contains certain forward-looking statements concerning Calyx and/or its subsidiaries, as well as other expectations, plans, goals, objectives, information or statements about future events, conditions, or performance that may constitute “forward-looking statements” or “forward-looking information” under applicable securities legislation. Such statements or information involve substantial known and unknown risks and uncertainties, certain of which are beyond Calyx’s control. Such forward-looking statements or information are based on a number of assumptions, which may prove to be incorrect.
Although Calyx believes that the expectations reflected in such forward-looking statements or information are reasonable, undue reliance should not be placed on forward-looking statements because Calyx can give no assurance that such expectations will prove to be correct. Forward-looking statements or information are based on current expectations, estimates and projections that involve a number of risks and uncertainties which could cause actual results to differ materially from those anticipated by Calyx and described in the forward-looking statements or information.
The forward-looking statements or information contained in this news release are made as of the date hereof and Calyx undertakes no obligation to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise unless so required by applicable securities laws or the TSX Venture Exchange. The forward-looking statements or information contained in this news release are expressly qualified by this cautionary statement.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
President & CEO